Meta Pixel

News and Announcements

How to Target Wholesale Investors in Australia

  • Published March 29, 2026 6:38AM UTC
  • Publisher Wholesale Investor
  • Categories Capital Insights, Capital Raising Tips, Trending

Targeting wholesale investors effectively means going beyond the legal definition of who qualifies and understanding who is actually likely to invest in your specific opportunity. Australia has a substantial and growing wholesale investor community, but it is not homogeneous. The investors who back seed-stage biotech companies are not the same investors who deploy into private credit funds. Targeting the right segment dramatically improves conversion rates and reduces the time and cost of raising capital.

Segmenting the Market

The 2026 Wholesale Investor Survey provides a detailed map of the Australian wholesale investor landscape across several key dimensions.

By Investor Type

Individual sophisticated investors are the largest segment at 44%. They typically invest personal capital, make independent decisions, and value direct access to management teams. Founder-investors (24%) bring operational expertise and are often attracted to sectors they understand from building their own companies. Fund managers (12%) have institutional mandates and structured due diligence processes. Advisors and intermediaries (14%) often invest alongside their clients.

By Sector Preference

Technology in general is the broadest draw at 39%, followed by deep tech (AI, robotics, quantum, space) at 37%. Private equity in established, cash-flow-positive businesses appeals to 35%. Healthtech and medtech at 32% and renewables, energy, and sustainability at 32% round out the top five. Private credit and yield strategies attract 27%, as does property and fintech.

Importantly, these preferences overlap. Many investors are active across multiple sectors. Understanding where your opportunity sits relative to these clusters helps you identify the largest addressable investor audience.

By Stage Preference

Series A and B opportunities with proven traction attract the largest cohort at 47%. Seed and pre-revenue investing appeals to 39%, reflecting a strong appetite for early-stage risk. Pre-IPO and late-stage opportunities where liquidity is within 24 months attract 38%. Private equity and buyout investing appeals to 35%.

By Ticket Size

The $25,000 to $100,000 bracket is the most common first ticket at 43%. The $100,000 to $250,000 range covers another 21%. At the upper end, 16% of investors write first cheques of $5 million or more, and 8% invest between $1 million and $5 million. Your minimum investment amount should align with the ticket size distribution of your target segment.

By Geographic Focus

Australia dominates at 71%, but international appetite is meaningful: 27% are interested in the US and North America, 20% in Singapore and Southeast Asia, 13% in the UK and Europe, and 10% in the Middle East and UAE. For companies with international operations or ambitions, this data supports a multi-geography investor targeting strategy.

Building an Investor Targeting Strategy

Step 1: Define Your Ideal Investor Profile

Combine the dimensions above to define your target. For example, individual sophisticated investors or founder-investors, focused on deep tech and SaaS, investing at the Series A stage, with a first ticket of $100,000 to $250,000, based in Australia with a secondary interest in the US. This level of specificity enables efficient outreach and higher conversion.

Step 2: Map Your Channels to Your Target

Different investor segments congregate in different places. Individual sophisticated investors are most efficiently reached through private capital marketplaces and targeted events. Fund managers require direct relationship building and structured due diligence presentations. Advisors are best engaged through partnership programmes that align their commercial incentives with your capital raising objectives.

Step 3: Craft Segment-Specific Messaging

A deep tech investor evaluating your AI company wants to hear about technical defensibility, your patent portfolio, and your team’s pedigree. A private equity investor looking at your established business wants to see EBITDA margins, growth trajectory, and management depth. The same company may need two entirely different investor narratives for two different investor segments.

Step 4: Build Multiple Touchpoints

Private-market investment decisions are rarely made in a single interaction. Plan for a minimum of three to five touchpoints before expecting a commitment: an initial introduction, an information session, a one-on-one meeting, data room access, and a follow-up. Use a CRM or pipeline tool to track engagement and prioritise follow-up.

The Role of Engagement Preferences

The 2026 survey reveals important preferences about how investors want to engage with portfolio companies after investing. The majority (62%) prefer an advisor or mentor relationship with ad-hoc strategic calls. About 42% are comfortable with passive monthly updates only. And 38% actively seek board-level involvement.

Understanding these preferences at the targeting stage helps you match the right investors with your company’s needs. If you need active board-level support, target the 38% who want that engagement. If you prefer a quiet capital, focus on the 42% who are happy with monthly updates.

Capital Insights
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain

In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]

Capital Insights
Silent Pain and Smart Monitors: The High-Stakes Race to De-Risk the Operating Theatre

Anesthesia has long been considered more “art” than science, leaving clinicians to manage high-stakes sedation with aging tools. Cortical Dynamics is changing the clinical reality with BARM 2.0—an AI-powered monitor that provides real-time visibility into the brain’s response to pain and sedation, backed by a global licence and cooperation agreement with Philips and a decade of R&D.

Join over 45,000+ sophisticated investors

Join Now